Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
The phenomenology and treatment of interferon-induced depression
2004
Immunotherapy of cancer in 2012
2012
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast Cancer
1999
The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
2014
Interim analysis: The alpha spending function approach
1994
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
2005
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
2004
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
Helper T cells regulate type-2 innate immunity in vivo
2002 Nature
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
2001 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
2001
Redirecting Th2 Responses in Allergy
1999
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
2011
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
2010 StandoutNobel
Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
2007
Atopic dermatitis: New insights and opportunities for therapeutic intervention
2000
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The development of allergic inflammation
2008 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Asthma
2001 Standout
New Therapies for Reducing Low-Density Lipoprotein Cholesterol
2014
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
2008
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
2014
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
IgE in asthma and atopy: cellular and molecular connections
1999
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
2012
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
1998 Standout
Immunologic changes associated with allergen immunotherapy
1998
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
2004
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Remodeling in Asthma
2009
Airway Mucus Function and Dysfunction
2010 Standout
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
2002
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Humanized Antibodies as Potential Therapeutic Drugs
1998
A COMPARISON OF GOODNESS-OF-FIT TESTS FOR THE LOGISTIC REGRESSION MODEL
1997
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
2010
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Oligonucleotide therapy of allergic asthma☆☆☆
1999
Immunological mechanisms of allergen-specific immunotherapy
2006
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
The molecular neurobiology of depression
2008 StandoutNature
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Anti‐immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti‐inflammatory activity and clinical efficacy
2005
Therapeutic strategies for allergic diseases
1999 Nature
Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma
2004
Asthma
2005
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
2010
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
A Proportional Hazards Model for the Subdistribution of a Competing Risk
1999 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Allergy and Allergic Diseases
2001
Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
1999
Spermidine in health and disease
2018 StandoutScience
Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo
1999
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
1999
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
2009
Effects of anti-IgE in asthmatic subjects
1998
Cancer Genome Landscapes
2013 StandoutScience
Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
2012
MicroRNA Regulation of Atherosclerosis
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Checking the Cox model with cumulative sums of martingale-based residuals
1993
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9
2009
The late asthmatic response is associated with baseline allergen‐specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin‐5
1999
Interferons, immunity and cancer immunoediting
2006
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
2001
IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESS
1999
Works of John Q. Su being referenced
A Lack-of-Fit Test for the Mean Function in a Generalized Linear Model
1991
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.
1994
Analysis of repeated markers used to predict progression of cancer
1998
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response.
1997
Treatment of ovarian cancer in elderly women: Mayo clinic-north central cancer treatment group studies
2010
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
1992
Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy
2010
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
1994
Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
2010
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.
1997
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol
1994
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
1999
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★
1997
Effect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects
1999
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
2013
Nonparametric Estimation for the Difference or Ratio of Median Failure Times
1993
Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B
2006
Interim analyses with repeated measurements in a sequential clinical trial
1990
Group Sequential Distribution-Free Methods for the Analysis of Multivariate Observations
1992